NIH launches ebola vaccine trials in Liberia

The research is being conducted jointly by the US National Institutes of Health (NIH) and the Liberian Ministry of Health.
462658336.jpg
1 of 10
A nurse speaks with a volunteer for the Ebola vaccine trials, which were launched at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people were given injections on the first day, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658358.jpg
2 of 10
A nurse speaks with a participant in the Ebola vaccine trials, which were launched at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people were given injections on the first day, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658398.jpg
3 of 10
Emmanuel Lansana, 43, takes part in a briefing before becoming the first person to be injected in the Ebola vaccine trials, which were launched at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Lansana, a physician's assistant, was the first of 12 people given injections on the first day, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658366.jpg
4 of 10
A nurse administers an injection on the first day of the Ebola vaccine study being conducted at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people were given injections Monday, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. In background of photo is Dr. Clifford Lane, Clinical Director of the U.S. National Institute for Allergy and Infectious Diseases. (Getty Images)
462658392.jpg
5 of 10
Nurses take a blood sample from Emmanuel Lansana, 43, the first person to take part in the Ebola vaccine trials being conducted at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Lansana, a physician's assistant, was the first of 12 people given injections, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658380.jpg
6 of 10
A doctor displays Ebola vaccines to be given in the vaccine trials which were launched at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people given injections on the first day, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658386.jpg
7 of 10
A nurse administers an injection to Emmanuel Lansana, 43, the first person to take part in the Ebola vaccine trials being conducted at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Lansana was the first of 12 people given injections, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658378.jpg
8 of 10
A nurse takes the temperature of a participant in the Ebola vaccine trials, which were launched at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people were given injections on the first day, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658344.jpg
9 of 10
A nurse administers an injection on the first day of the Ebola vaccine study being conducted at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people were given injections Monday, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)
462658332.jpg
10 of 10
Liberian pharmacists prepare the first batch of Ebola vaccines to be given in the vaccine trials, which were launched at Redemption Hospital, formerly an Ebola holding center, on February 2, 2015 in Monrovia, Liberia. Twelve people given injections on the first day, out of a planned 27,000 people in the Monrovia area. The clinical research study is being conducted jointly by the U.S. National Institutes of Health (NIH), and the Liberian Ministry of Health. The Ebola epidemic virus has killed at least 3,700 people in Liberia alone, the most of any country, and nearly 9,000 across in West Africa. (Getty Images)